Calamos Advisors’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,738
Closed -$290K 1057
2026
Q1
$290K Buy
+12,738
New +$301K ﹤0.01% 1033
2017
Q3
Sell
-185,766
Closed -$12.6M 626
2017
Q2
$12.6M Sell
185,766
-5,596
-3% -$382K 0.09% 256
2017
Q1
$12.9M Sell
191,362
-10,297
-5% -$686K 0.1% 250
2016
Q4
$12.5M Buy
+201,659
New +$11.9M 0.1% 235
2013
Q4
Sell
-8,483
Closed -$825K 634
2013
Q3
$825K Buy
8,483
+1,511
+22% +$139K 0.01% 492
2013
Q2
$625K Buy
+6,972
New +$575K ﹤0.01% 505

Other funds holding ENOV

Calamos Advisors's ENOV Position: Q2 2026 in Review

Calamos Advisors sold out of Enovis (ENOV) in Q2 2026, closing a stake of 12,738 shares — an estimated $290K sold.

Calamos Advisors first reported a position in ENOV in Q2 2013 and held it in 6 quarters. The position peaked at $12.9M in Q1 2017. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Calamos Advisors reported no remaining Enovis position as of Q2 2026 after selling out during the quarter.
  • Calamos Advisors sold 12,738 Enovis shares in Q2 2026, an estimated $290K.
  • Calamos Advisors first reported a position in Enovis in Q2 2013 and held it in 6 quarters.
  • Calamos Advisors's Enovis position peaked at $12.9M in Q1 2017.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.